Suppr超能文献

基于微流控技术的高通量细胞药物筛选系统的研究进展

[Research advances of high-throughput cell-based drug screening systems based on microfluidic technique].

作者信息

Liang Yixiao, Pan Jianzhang, Fang Qun

机构信息

Institute of Microanalytical Systems, Department of Chemistry, Zhejiang University, Hangzhou 310058, China.

出版信息

Se Pu. 2021 Jun;39(6):567-577. doi: 10.3724/SP.J.1123.2020.07014.

Abstract

Drug screening is the process of screening new drugs or leading compounds with biological activity from natural products or synthetic compounds, and it plays an essential role in drug discovery. The discovery of innovative drugs requires the screening of a large number of compounds with appropriate drug targets. With the development of genomics, proteomics, metabolomics, combinatorial chemistry, and other disciplines, the library of drug molecules has been largely expanded, and the number of drug targets is continuously increasing. High-throughput screening systems enable the parallel analysis of thousands of reactions through automated operation, thereby enhancing the experimental scale and efficiency of drug screening. Among them, cell-based high-throughput drug screening has become the main screening mode because it can provide a microenvironment similar to human physiological conditions. However, the current high-throughput screening systems are mainly built based on multiwell plates, which have several disadvantages such as simple cell culture conditions, laborious and time-consuming operation, and high reagent consumption. In addition, it is difficult to achieve complex drug combination screening. Therefore, there is an urgent need for rapid and low-cost drug screening methods to reduce the time and cost of drug development. Microfluidic techniques, which can manipulate and control microfluids in microscale channels, have the advantages of low consumption, high efficiency, high throughput, and automation. It can overcome the shortcomings of screening systems based on multi-well plates and provide an efficient and reliable technical solution for establishing high-throughput cell-based screening systems. Moreover, microfluidic systems can be flexibly changed in terms of cell culture materials, chip structure design, and fluid control methods to enable better control and simulation of cell growth microenvironment. Operations such as cell seeding, culture medium replacement or addition, drug addition and cleaning, and cell staining reagent addition are usually involved in cell-based microfluidic screening systems. These operations are all based on the manipulation of microfluids. This paper reviews the research advances in cell-based microfluidic screening systems using different microfluidic manipulation modes, namely perfusion flow mode, droplet mode, and microarray mode. In addition, the advantages and disadvantages of these systems are summarized. Moreover, the development prospects of high-throughput screening systems based on microfluidic techniques has been looked forward. Furthermore, the current problems in this field and the directions to overcome these problems are discussed.

摘要

药物筛选是从天然产物或合成化合物中筛选具有生物活性的新药或先导化合物的过程,它在药物发现中起着至关重要的作用。创新药物的发现需要筛选大量具有合适药物靶点的化合物。随着基因组学、蛋白质组学、代谢组学、组合化学等学科的发展,药物分子库得到了极大的扩展,药物靶点的数量也在不断增加。高通量筛选系统能够通过自动化操作对数千个反应进行并行分析,从而提高药物筛选的实验规模和效率。其中,基于细胞的高通量药物筛选已成为主要的筛选模式,因为它可以提供类似于人体生理条件的微环境。然而,目前的高通量筛选系统主要基于多孔板构建,存在细胞培养条件简单、操作繁琐耗时、试剂消耗量大等缺点。此外,难以实现复杂药物组合筛选。因此,迫切需要快速、低成本的药物筛选方法,以降低药物开发的时间和成本。微流控技术能够在微尺度通道中操纵和控制微流体,具有消耗低、效率高、高通量和自动化等优点。它可以克服基于多孔板的筛选系统的缺点,为建立基于细胞的高通量筛选系统提供高效可靠的技术解决方案。此外,微流控系统在细胞培养材料、芯片结构设计和流体控制方法方面可以灵活变化,以便更好地控制和模拟细胞生长微环境。基于细胞的微流控筛选系统通常涉及细胞接种、培养基更换或添加、药物添加和清洗以及细胞染色试剂添加等操作。这些操作均基于对微流体的操纵。本文综述了基于细胞的微流控筛选系统在不同微流控操纵模式(即灌注流模式、液滴模式和微阵列模式)下的研究进展。此外,总结了这些系统的优缺点。同时,展望了基于微流控技术的高通量筛选系统的发展前景。此外,还讨论了该领域目前存在的问题以及克服这些问题的方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0783/9404090/9180bd8b5161/cjc-39-06-567-img_1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验